Inventor · disambiguated record
Steve Cartt
Also filed as: CARTT STEVE
13 granted patents·14 pending applications·87 citations·filing 2007–2025
92Inventor score
Files withHALE BIOPHARMA VENTURES LLC7NEURELIS INC7QUESTCOR PHARMACEUTICALS INC6MALLINCKRODT ARD IP LTD4CARTT STEVE3
Top patents by PatentIndex Score
27 records- 0196US12268664B1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2024·Granted Apr 8, 2025·3 cites·18 claims
- 0294US12337061B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2022·Granted Jun 24, 2025·2 cites·62 claims
- 0394US11241414B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Feb 8, 2022·2 cites·18 claims
- 0494US8530463B2Multimodal particulate formulationsCARTT STEVE·Filed 2008·Granted Sep 10, 2013·34 cites·24 claims
- 0593US12324852B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Jun 10, 2025·2 cites·31 claims
- 0693US11793786B2Administration of benzodiazepine compositionsNEURELIS INC·Filed 2021·Granted Oct 24, 2023·2 cites·27 claims
- 0789US8895546B2Administration of benzodiazepine compositionsCARTT STEVE·Filed 2012·Granted Nov 25, 2014·10 cites·22 claims
- 0887US7608616B1Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomniaQUESTCOR PHARMACEUTICALS INC·Filed 2008·Granted Oct 27, 2009·5 cites·2 claims
- 0985US10232018B2ACTH for treatment of acute respiratory distress syndromeMALLINCKRODT ARD IP LTD·Filed 2014·Granted Mar 19, 2019·8 cites·21 claims
- 1084US10286041B2ACTH prophylactic treatment of renal disordersMALLINCKRODT ARD IP LTD·Filed 2016·Granted May 14, 2019·6 cites·15 claims
- 1184US9763876B2Administration of benzodiazepine compositionsHALE BIOPHARMA VENTURES LLC·Filed 2014·Granted Sep 19, 2017·7 cites·36 claims
- 1283US2025281394A1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2025·Application pending·0 cites
- 1383US2023104144A1Administration of benzodiazepine compositionsNEURELIS INC·Filed 2022·Application pending·0 cites
- 1479US8796416B1ACTH prophylactic treatment of renal disordersCARTT STEVE·Filed 2011·Granted Aug 5, 2014·5 cites·16 claims
- 1572US2009258865A1Administration of benzodiazepine compositionsHALE BIOPHARMA VENTURES LLC·Filed 2009·Application pending·0 cites
- 1670US9550822B2ACTH prophylactic treatment of renal disordersQUESTCOR PHARMACEUTICALS INC·Filed 2014·Granted Jan 24, 2017·1 cites·13 claims
- 1770US2010016294A1Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomniaQUESTCOR PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1861US2018235929A1Administration of benzodiazepine compositionsHALE BIOPHARMA VENTURES LLC·Filed 2018·Application pending·0 cites
- 1959US2020038320A1Multimodal particulate formulationsHALE BIOPHARMA VENTURES LLC·Filed 2019·Application pending·0 cites
- 2057US2019216901A1Acth prophylactic treatment of renal disordersMALLINCKRODT ARD IP LTD·Filed 2019·Application pending·0 cites
- 2157US2017196884A1Administration of benzodiazepine compositionsHALE BIOPHARMA VENTURES LLC·Filed 2017·Application pending·0 cites
- 2256US2008021074A1Pharmaceutical Compositions and Related Methods of TreatmentQUESTCOR PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2355US2019160150A1Acth for treatment of acute respiratory distress syndromeMALLINCKRODT ARD IP LTD·Filed 2019·Application pending·0 cites
- 2454US2014170220A1Multimodal particulate formulationsHALE BIOPHARMA VENTURES LLC·Filed 2013·Application pending·0 cites
- 2550US2014294923A1Acth for treatment of migraine headacheQUESTCOR PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2648US2016310421A1Multimodal particulate formulationsHALE BIOPHARMA VENTURES LLC·Filed 2015·Application pending·0 cites
- 2747US2008279784A1Nasal administration of benzodiazepinesQUESTCOR PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steve Cartt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →